Minister Bandar bin Ibrahim Al-Khorayef, who heads the country’s vaccines and biopharmaceuticals industry committee, explained that the investments will be implemented in two phases. The first includes techniques for manufacturing basic vaccines for children, plasma and insulin.
He added that the second phase of investments aims to localize the techniques of immunological drugs and those for cancer treatment.
The minister pointed out that the biopharmaceutical sector recorded the fastest growth rate in the market among the pharmaceutical sectors by 17 percent, adding that the investments would contribute to reducing the high cost borne by the country, which currently imports 100 percent of its needs of vaccines and vital medicines.
#Saudi #Arabia #invests #billion #manufacturing #vaccines #medicines
